Latest News

No-see docs are know-nothings when it comes to new drug info, study suggests

May 22, 2012

An AstraZeneca-sponsored study found that doctors who don't see sales reps are far slower to respond to medical developments such as new products, black box warnings and clinical trials data.
 

E-prescriptions boost adherence data

May 22, 2012

A new study by Surescripts, the nation's largest e-prescription network, suggests that saving patients the trouble of toting a prescription to a store increases the likelihood that they will get it filled and take their meds.
 

How CDC's hep.-C testing advice benefits drugmakers now

May 22, 2012

The CDC's proposal that all US baby boomers get a one-time test for the hepatitis C virus has already given a boost to drugmakers in the antiviral space.
 

PhRMA's Washington wish list

May 21, 2012

PhRMA presented Washington with its legislative wish list - and a warning that plenty of other countries are trying to woo the industry away from the US.
 

Study: Young Latinas are key decision makers, prefer English

May 21, 2012

Effectively communicating health messages to the Hispanic community requires one key thing: reaching Latinas between the ages of 25 and 35.
 

Pharmas are from Mars, Payers are from Venus

May 17, 2012

Pharma needs to step up its sales pitch, looking beyond a drug's top attributes, to convince payers that their drugs are worth the cost.
 

Goodbye Plavix, hello competition

May 17, 2012

Long-running blockbuster Plavix has joined the patent graveyard, and competitors are all in.
 

Indian conglomerate buys Manhattan Research parent for $635m

May 16, 2012

A Mumbai-based pharma custom manufacturing firm is buying the parent company of Manhattan Research.
 

Sales forces shrank in 2011, but not everywhere

May 16, 2012

Pharmas shrank their US sales forces by 7% between 2010 and 2011, but the pain wasn't shared evenly between the biggest of pharmas, as a number of players scaled up.
 

National plan seeks Alzheimer's treatment by 2025

May 15, 2012

HHS Secretary Kathleen Sebelius released the National Plan to Address Alzheimer's Disease at the second day of the National Alzheimer's Research Summit Tuesday.
 

Agency Spotlight

Click here for MM&M’s guide to Healthcare Agencies

Latest Issue

Get Back in Shape
As pharma deals with old, expiring brands and not enough newcomers to replace them, we look at industry's regimen for regaining form. PLUS: How cutbacks are impacting CME, and some lessons on how to keep your focus on customers as well as products

The Interactive Guide

The Interactive Guide
In this special supplement to MM&M, you'll find plenty of trends, data, insights, tips and examples to help you make the most of digital opportunities.

Latest Features

Pharma Report 2012: Get Back in Shape

Med Ed Report: Show Me the Money

Product Communications: When Love Is Blind

MM&M Awards: Dream Team 2012

Headliner: Hayes' open-door policy opens doors

 Subscribe to the RSS for this page  [view all our RSS feeds here]

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!

MAHF Ceremony 2012

Photos from the Medical Advertising Hall of Fame Awards ceremony
 
Popular Topics
Acquisition Adherence App Celebrity Clinical Trial Co-Marketing Conflict Of Interest Diabetes Diagnostics Digital Direct To Consumer (DTC) Disease Awareness Downsize Education & Awareness FDA Government Guidance Health Plans HMOs Hospitals Insurers Law Marketing Research Mobile Sales Force